KMT5A and cancer: To this end, several SETD8‐targeting microRNAs, such as miR‐502, miR‐7, or miRNA‐127‐3p (Milite et al., 2016), have been shown to abrogate malignant attributes of cancer—proliferation, EMT, and invasion.